Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00201136 · ClinicalTrials.gov registry record · Phase 2

Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk

A Phase 2 study, sponsored by Duke University.

Completed
Registry status
Phase 2
Development phase
574
Enrollment target

NCT00201136: Completed Phase 2 study, sponsored by Duke University.

NCT00201136 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 574 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (332% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00201136, a Phase 2 study, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 2
Development phase
574 participants
Enrollment target

Study Summary

This study will test the separate and combined effects of a continuous quality improvement (CQI) intervention for physicians (MDs) and a behavioral intervention for patients on blood pressure control.

Interventions

  • BEHAVIORAL Lifestyle interventions to lower blood pressure for patients
  • BEHAVIORAL MD CQI-type intervention

Trial Details

FieldValue
Enrollment Target 574 participants
Start Date 2004-02
Est. Completion 2008-08
Phase Phase 2
Duke University

1,725 total trials

What the finished NCT00201136 record still lists

NCT00201136 is an interventional study that assigns participants to a tested intervention. The registered 574 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (332% higher).

The record links to 0 conditions, and to 2 interventions - of which Lifestyle interventions to lower blood pressure for patients is the first listed.

NCT00201136 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00201136 about?

NCT00201136 is a clinical study titled "Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk". This study will test the separate and combined effects of a continuous quality improvement (CQI) intervention for physicians (MDs) and a behavioral intervention for patients on blood pressure control.

What is the current status of trial NCT00201136?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 574 participants. The study started on 2004-02. Estimated completion is 2008-08.

What interventions are being tested in trial NCT00201136?

The interventions under investigation include: Lifestyle interventions to lower blood pressure for patients (BEHAVIORAL), MD CQI-type intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00201136?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00201136's enrollment target sits among peer trials

574 59th of 2000 higher than 1,942 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07349537 · 574 participants · Phase 1

    Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • NCT02610439 · 575 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

  • NCT05919264 · 575 participants · Phase 1

    FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • NCT06583148 · 575 participants · NA

    A Smoke-Free Home Intervention in Tribal Communities

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00201136, the US trial registry maintained by the National Library of Medicine. NCT00201136 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.